You just read:

Audentes Therapeutics Announces MHRA Approval of Clinical Trial Authorisation Application for AT132 to Treat X-Linked Myotubular Myopathy

News provided by

Audentes Therapeutics, Inc.

03 Oct, 2017, 07:00 BST